Gracey Craig, Omada Health’s chief accounting officer, sold 644 shares at $21.73 per share on 2026-09-09. She retained 14,412 shares, and the transaction represented about 4.3% of her prior holding, giving investors the disclosed scale of the insider sale relative to her position.
Key Highlights
- Gracey Craig retained 14,412 Omada Health shares after the transaction.
- The sale represented about 4.3% of Craig’s prior shareholding.
- The transaction carried SEC code S, denoting an open-market sale.
Omada Health, Inc. (NASDAQ: OMDA) Chief Accounting Officer Gracey Craig sold 644 shares at $21.73 per share. The transaction occurred on 9 September 2026.
Open-Market Sale Recorded Under Code S
Gracey Craig serves as Omada Health’s chief accounting officer. The transaction carries SEC transaction code S, which denotes an open-market sale. Each share changed hands at $21.73. The sale involved 644 Omada Health shares, matching the number reported for the transaction. Code S describes the transaction type, while the reported price applies to each of the 644 shares.
Remaining Position Represents 4.3% Comparison
Craig owned 14,412 shares after completing the transaction. The sale represented about 4.3% of her prior holding. That percentage compares the shares sold with the position Craig held before the transaction. The post-transaction holding remains 14,412 shares.
FAQs
Q: How many Omada Health shares did Gracey Craig sell?
A: Gracey Craig sold 644 Omada Health shares at $21.73 per share. She served as the company’s chief accounting officer when the transaction occurred on 9 September 2026.
Q: What was the impact of Gracey Craig’s OMDA stock sale?
A: The OMDA stock transaction left Craig with 14,412 shares. The sale represented about 4.3% of her prior holding in Omada Health.
Q: Was the Omada Health insider transaction an open-market sale?
A: Yes. The Omada Health insider transaction used SEC code S, which identifies an open-market sale, and each share was sold at $21.73.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.